HIF and the Lung
- 15 January 2011
- journal article
- review article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 183 (2), 152-156
- https://doi.org/10.1164/rccm.201009-1393pp
Abstract
No abstract availableThis publication has 61 references indexed in Scilit:
- HIF-1 mediates pathogenic inflammatory responses to intestinal ischemia-reperfusion injuryAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2010
- HIF-2α deletion promotes Kras-driven lung tumor developmentProceedings of the National Academy of Sciences, 2010
- Treatment with HIF-1α Antagonist PX-478 Inhibits Progression and Spread of Orthotopic Human Small Cell Lung Cancer and Lung Adenocarcinoma in MiceJournal of Thoracic Oncology, 2010
- Human cancers converge at the HIF-2α oncogenic axisProceedings of the National Academy of Sciences, 2009
- Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1American Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularizationProceedings of the National Academy of Sciences, 2009
- Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growthProceedings of the National Academy of Sciences, 2008
- Inflammatory Levels of Nitric Oxide Inhibit Airway Epithelial Cell Migration by Inhibition of the Kinase ERK1/2 and Activation of Hypoxia-inducible Factor-1αPublished by Elsevier BV ,2008
- Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrixProceedings of the National Academy of Sciences, 2006
- Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylationThe EMBO Journal, 2001